SUMATRIPTAN SUCCINATE INJECTION
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Defense Logistics Agency awarded contract SPE2DP26F8721 to DMS Pharmaceutical Group Inc (CAGE 1UNB0) on August 5, 2026, as a delivery order under master contract SPE2DX25D9900. This firm-fixed-price award is for the procurement of Sumatriptan Succinate Injection (NSN 6505016724394) with a total contract value of $676.30. The order consists of a single line item for 2.000 KT at a unit price of $338.15, with a strict quantity variance of zero percent. The product must be delivered by August 5, 2026, to the Medical Logistics company at Fort Bragg, North Carolina. Terms are FOB Destination, with the contractor responsible for all transportation costs and risks. Shipping must be conducted via traceable means, and the use of parcel post is explicitly prohibited. Inspection and acceptance will occur at the destination. Packaging must include the tracking identifier M/F: (TCN) W50YF262160081 and be routed through the DLA distribution center in Oklahoma City.
General Info
Contract Value
$676.3Place of Performance
Not specifiedSet-Aside
Awardee
DMS PHARMACEUTICAL GROUP INCAward Issued Date
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
